Inhibition of tumor necrosis factor–related apoptosis-inducing ligand (TRAIL) reverses experimental pulmonary hypertension

Pulmonary arterial hypertension (PAH) is a life-threatening disease characterized by the progressive narrowing and occlusion of small pulmonary arteries. Current therapies fail to fully reverse this vascular remodeling. Identifying key pathways in disease pathogenesis is therefore required for the d...

Descripción completa

Detalles Bibliográficos
Autores principales: Hameed, Abdul G., Arnold, Nadine D., Chamberlain, Janet, Pickworth, Josephine A., Paiva, Claudia, Dawson, Sarah, Cross, Simon, Long, Lu, Zhao, Lan, Morrell, Nicholas W., Crossman, David C., Newman, Christopher M.H., Kiely, David G., Francis, Sheila E., Lawrie, Allan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Rockefeller University Press 2012
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3478928/
https://www.ncbi.nlm.nih.gov/pubmed/23071256
http://dx.doi.org/10.1084/jem.20112716

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3478928/
https://www.ncbi.nlm.nih.gov/pubmed/23071256
http://dx.doi.org/10.1084/jem.20112716

Ejemplares similares